BRIVENTION PHARMACEUTICAL SHANGHAI INC has a total of 13 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2017. It filed its patents most often in Australia, Brazil and Canada. Its main competitors in its focus markets pharmaceuticals, foods and drinks and organic fine chemistry are HERBALSCIENCE SINGAPORE PTE LTD, PRONOVA BIOPHARMA NORGE AS and THETIS PHARMACEUTICALS LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 1 | |
#2 | Brazil | 1 | |
#3 | Canada | 1 | |
#4 | Colombia | 1 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | Israel | 1 | |
#7 | Japan | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Mexico | 1 | |
#10 | Philippines | 1 | |
#11 | Singapore | 1 | |
#12 | United States | 1 | |
#13 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Foods and drinks | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Acyclic or carbocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Special foods | |
#4 | Medical preparations | |
#5 | Foods |
# | Name | Total Patents |
---|---|---|
#1 | Yamamura Michio | 9 |
#2 | Tateishi Narito | 8 |
#3 | Michio Yamamura | 3 |
#4 | Narito Tateishi | 3 |
#5 | Tateishi Shigeto | 1 |
Publication | Filing date | Title |
---|---|---|
AU2017340594A1 | Composition comprising combination of TRH analog with arundic acid, and pharmaceutically acceptable salt of arundic acid |